ALEMBIC PHARMACEUTICALS LTD.

NSE : APLLTDBSE : 533573ISIN CODE : INE901L01018Industry : Pharmaceuticals & DrugsHouse : Alembic
BSE938.008 (+0.86 %)
PREV CLOSE ( ) 930.00
OPEN PRICE ( ) 933.55
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 3285
TODAY'S LOW / HIGH ( )915.25 948.95
52 WK LOW / HIGH ( )528.95 1093.05
NSE938.357.3 (+0.78 %)
PREV CLOSE( ) 931.05
OPEN PRICE ( ) 929.95
BID PRICE (QTY) 938.35 (58)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 69069
TODAY'S LOW / HIGH( ) 913.95 948.75
52 WK LOW / HIGH ( )527.35 1094
( in Million)
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Profit Before Tax3545.906253.9013680.809998.207493.20
Adjustment4876.304177.501024.202782.801175.70
Changes In working Capital-575.70-3673.602383.00-5928.401115.60
Cash Flow after changes in Working Capital7846.506757.8017088.006852.609784.50
Cash Flow from Operating Activities7239.505523.5014633.804491.508119.70
Cash Flow from Investing Activities-4475.90-3719.70-8388.00-7316.30-7556.00
Cash Flow from Financing Activities-2619.60-2173.50-5974.201548.50590.30
Net Cash Inflow / Outflow144.00-369.70271.60-1276.301154.00
Opening Cash & Cash Equivalents610.90980.60718.301990.60837.40
Cash & Cash Equivalent on Amalgamation / Take over / MergerNANANANANA
Cash & Cash Equivalent of Subsidiaries under liquidationsNANANANANA
Translation adjustment on reserves / op cash balalces frgn subsidiariesNANANANANA
Effect of Foreign Exchange Fluctuations-0.10NA-9.304.10-0.70
Closing Cash & Cash Equivalent754.80610.90980.60718.401990.70

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.